To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
Clinical trial NCT01768572 · COMPLETED
Trial details
- NCT number
- NCT01768572
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.